By all accounts, a combination of colon cancer, diabetes and high blood pressure can be a recipe for medical disaster. Now, a new study led by a surgical oncologist and researcher at Temple University School of Medicine and Fox Chase Cancer Center has shown just how deadly this mix can be. In a retrospective analysis of more than 36,000 patients with colon cancer, investigators showed that those with early stage disease and diabetes or high blood pressure – two components of metabolic syndrome – have a greater risk for the cancer returning after treatment and of dying compared to patients with colon cancer who do not have either condition. Read more here.
Study mentioned: Yang Y, et al. Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients. Cancer. Article first published online: 20 Dec 2012.
No comments:
Post a Comment